Dashboard
Manage Tickers

ABEOABEONA THERAPEUTICS INC.

Nasdaq abeonatherapeutics.com


$ 5.54 $ -0.08 (-1.42 %)    

Friday, 06-Sep-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 5.55
$ 5.54 x 500
-- x --
-- - --
$ 3.05 - $ 9.01
193,194
na
240.39M
$ 1.16
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-18-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-29-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-13-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-24-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 03-16-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-16-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-30-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-16-2015 09-30-2015 10-Q
37 08-14-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-31-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-abeona-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Abeo...
08/14/2024 11:30:36

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $15...

the-centers-for-medicare-and-medicaid-services-has-granted-a-product-specific-procedure-code-icd-10-pcs-for-abeona-therapeutics-prademagene-zamikeracel-pz-cel-investigational-autologous-cell-based-gene-therapy-currently-in-development-for-recessive-dystrophic-epidermolysis-bullosa
The Centers For Medicare And Medicaid Serv...
08/13/2024 11:34:01

If pz-cel receives U.S. marketing approval, this code will allow for efficient and accurate documentation, billing, and analysi...

abeona-therapeutics-q2-eps-026-beats-036-estimate-cash-balance-123m
Abeona Therapeutics Q2 EPS $(0.26) Beats $...
08/12/2024 11:33:10

abeona-therapeutics-concludes-type-a-meeting-with-fda-to-align-on-upcoming-pz-cel-bla-resubmission-continues-to-expect-to-resubmit-bla-in-second-half-of-2024
Abeona Therapeutics Concludes Type A Meeti...
08/12/2024 11:31:33

hc-wainwright--co-reiterates-buy-on-abeona-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Abeo...
07/12/2024 10:10:39

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $15...

abeona-therapeutics-and-beacon-therapeutics-announced-an-agreement-by-which-beacon-will-evaluate-abeonas-patented-aav204-capsid-for-the-development-and-commercialization-of-potential-gene-therapies-for-select-ophthalmology-indications
Abeona Therapeutics And Beacon Therapeutic...
07/11/2024 11:35:00

Under the terms of the agreement, Beacon will have the right to evaluate, for a 12-month period, the AAV204 capsid for potentia...

hc-wainwright--co-initiates-coverage-on-abeona-therapeutics-with-buy-rating-announces-price-target-of-15
HC Wainwright & Co. Initiates Coverage On ...
07/03/2024 10:18:00

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Abeona Therapeutics (NASDAQ:ABEO) with a Buy rating...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/30/2024 20:31:17

stifel-initiates-coverage-on-abeona-therapeutics-with-buy-rating-announces-price-target-of-21
Stifel Initiates Coverage On Abeona Therap...
05/30/2024 12:05:11

Stifel analyst Dae Gon Ha initiates coverage on Abeona Therapeutics (NASDAQ:ABEO) with a Buy rating and announces Price Targ...

cantor-fitzgerald-maintains-overweight-on-abeona-therapeutics-lowers-price-target-to-21
Cantor Fitzgerald Maintains Overweight on ...
05/16/2024 15:14:51

Cantor Fitzgerald analyst Kristen Kluska maintains Abeona Therapeutics (NASDAQ:ABEO) with a Overweight and lowers the price ...

abeona-therapeutics-estimates-that-its-current-cash-and-cash-equivalents-restricted-cash-and-short-term-investments-of-627m-credit-facility-and-proceeds-of-75m-from-underwritten-offering-in-may-is-expected-to-provide-cash-runway-into-2026
Abeona Therapeutics Estimates That Its Cur...
05/15/2024 11:43:43

abeona-therapeutics-q1-2024-gaap-eps-116-misses-051-estimate
Abeona Therapeutics Q1 2024 GAAP EPS $(1.1...
05/15/2024 11:40:38

abeona-therapeutics-prices-an-underwritten-offering-of-1228m-shares-pre-funded-warrants-to-purchase-61m-shares-at-407-per-share-or-40699-per-pre-funded-warrant-with-gross-proceeds-of-approximately-75m
Abeona Therapeutics Prices An Underwritten...
05/03/2024 11:35:36

crude-oil-moves-higher-general-motors-earnings-top-views
Crude Oil Moves Higher; General Motors Ear...
04/23/2024 18:31:47

why-nucor-shares-are-trading-lower-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Nucor Shares Are Trading Lower? Here A...
04/23/2024 17:53:09

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
04/23/2024 16:31:13

dow-jumps-over-200-points-us-services-pmi-falls-in-april
Dow Jumps Over 200 Points; US Services PMI...
04/23/2024 16:21:23

us-stocks-higher-pepsico-posts-upbeat-earnings
US Stocks Higher; PepsiCo Posts Upbeat Ear...
04/23/2024 13:49:59

fda-rejects-approval-of-abeona-therapeutics-skin-disorder-treatment-shares-sink
FDA Rejects Approval Of Abeona Therapeutic...
04/23/2024 13:43:12

Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Man...

cantor-fitzgerald-reiterates-overweight-on-abeona-therapeutics-maintains-36-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/23/2024 12:47:37

Cantor Fitzgerald analyst Kristen Kluska reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Overweight and maintains $36 pr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION